DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-799 Cr | ₹-799 Cr | ₹-797 Cr | ₹-532 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-799 Cr |
Mar2024 | ₹-799 Cr |
Mar2023 | ₹-797 Cr |
Mar2022 | ₹-532 Cr |
Mar2021 | ₹-35 Cr |
How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-799 Cr | Negative | |
Mar2024 | ₹-799 Cr | Negative | |
Mar2023 | ₹-797 Cr | Negative | |
Mar2022 | ₹-532 Cr | Negative | |
Mar2021 | ₹-35 Cr | - |
Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹162,045.3 Cr | -0.5% | -10.1% | 21.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 2.6% | -5.1% | -6.4% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 4.7% | 4.8% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 0.6% | 5.2% | 8.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 4.3% | -0.7% | -11.4% | Stock Analytics | |
MANKIND PHARMA | ₹102,043.0 Cr | -3% | -7% | 13% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0.5% |
-10.1% |
21.8% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses